841-850
Original Article
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
Katharina Götze, Uwe Platzbecker, Aristoteles Giagounidis, Detlef Haase and Michael Lübbert, et al.
851-859
Original Article
Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study
Elias Hallack Atta, Danielle Saldanha Peixoto Dias, Vera Lúcia Neves Marra and Alexandre Mello de Azevedo
861-871
Original Article
Open AccessDasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
Lina Han, Jan Jacob Schuringa, André Mulder and Edo Vellenga
873-876
Original Article
Can decreasing smoking prevalence reduce leukemia mortality?
Ramya Varadarajan, Michael K. Cummings, Andrew J. Hyland, Eunice S. Wang and Meir Wetzler
877-882
Original Article
Open AccessArginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients
Wendell Vilas-Boas, Bruno A. V. Cerqueira, Angela M. D. Zanette, Mitermayer G. Reis and Manoel Barral-Netto, et al.
883-888
Original Article
Complex interaction of Hb Q-Thailand and Hb E with α0-thalassemia and hereditary persistence of fetal hemoglobin in a Chinese family
Weidong Zheng, Yanhui Liu, Dong Chen, Kabin Rong and Yanfen Ge, et al.
889-896
Original Article
Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin’s lymphoma
Anastasios Chatzitolios, Ioannis Venizelos, Gregory Tripsiannis, George Anastassopoulos and Nikolaos Papadopoulos
897-904
Original Article
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma
Tsuneaki Hirakawa, Hiroki Yamaguchi, Norio Yokose, Seiji Gomi and Koiti Inokuchi, et al.
905-912
Original Article
Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety
Sung Sook Lee, Cheolwon Suh, Bong-Seog Kim, Jooseop Chung and Young-Don Joo, et al.
913-918
Original Article
Serological response to influenza vaccine after hematopoetic stem cell transplantation
S. Songül Yalçın, Meda Kondolot, Nurhan Albayrak, A. Başak Altaş and Yasemin Karacan, et al.
919-926
Original Article
Open AccessEconomic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands
Jeroen P. Jansen, Amy K. O’Sullivan, Elly Lugtenburg, Lambert F. R. Span and Jeroen J. W. M. Janssen, et al.
927-933
Original Article
Open AccessPharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial
Cornelius F. Waller, Miguel Bronchud, Stuart Mair and Rodeina Challand
935-937
Letter to the Editor
Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report
Stefano Sansone, Johanna Rottensteiner, Judith Stocker, Carlo Rosanelli and Christian Josef Wiedermann
939-940
Letter to the Editor
Hyperlipidemic myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia and Francesco Lauria
941-943
Letter to the Editor
Areas with high soil percolation by herbicides have higher incidence of low-grade non-Hodgkin lymphomas
Rita Fazzi, Chiara Manetti, Daniele Focosi, Lucia Miligi and Alessandra Benvenuti, et al.
945-947
Letter to the Editor
Two case reports of non-secretary-Ig types of lymphoplasmacytic lymphoma (LPL)
Kichinosuke Kobayashi, Taiji Yokote, Yuji Hirata, Shoko Nakayama and Nobuya Hiraoka, et al.
949-951
Letter to the Editor
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA)
Andrea Tendas, Pasquale Niscola, Teresa Dentamaro, Luca Cupelli and Gigliola Di Matteo, et al.